APA (7th ed.) Citation

Mai, E. K., Bertsch, U., Schlenzka, J., Hillengaß, J., Raab, M., Merz, M., . . . Goldschmidt, H. (2019). Bortezomib-based induction therapy with high or low-dose dexamethasone in newly diagnosed, transplant-eligible multiple myeloma. Leukemia, 33(1), . https://doi.org/10.1038/s41375-018-0195-9

Chicago Style (17th ed.) Citation

Mai, Elias K., et al. "Bortezomib-based Induction Therapy with High or Low-dose Dexamethasone in Newly Diagnosed, Transplant-eligible Multiple Myeloma." Leukemia 33, no. 1 (2019). https://doi.org/10.1038/s41375-018-0195-9.

MLA (9th ed.) Citation

Mai, Elias K., et al. "Bortezomib-based Induction Therapy with High or Low-dose Dexamethasone in Newly Diagnosed, Transplant-eligible Multiple Myeloma." Leukemia, vol. 33, no. 1, 2019, https://doi.org/10.1038/s41375-018-0195-9.